Health news in France is structured around regulatory decisions, institutional reports, and epidemiological data that concretely change patient care. Following these developments allows for anticipating changes in the care pathway, prevention, or reimbursement of medical procedures.
Chronic diseases and Cnam projections: what the Charges and Products 2027 report predicts
The Charges and Products 2027 report, published by Cnam, serves as a compass for the orientations of the French healthcare system. It highlights the continuous rise of chronic diseases across the territory: according to its projections, nearly one in two people could be affected by 2035.
The financial burden of these conditions could reach up to 70% of the expenses reimbursed by Health Insurance. In light of this finding, the report targets several levers for action: early screening in children, enhanced cardiovascular prevention, anti-tobacco policies, and improved dietary habits.
Another notable proposal: Cnam recommends making the Nutri-Score mandatory on packaged products. Such a measure would transform nutritional labeling rules for the entire agri-food sector. To follow all the news on zone-sante.fr, this type of regulatory signal deserves special attention.
Prevention appointments: a precise legal framework since the decree of July 28, 2026
The decree of July 28, 2026, published in the Official Journal, sets the modalities for prevention appointments included in the public health code. The text divides the population into four age groups: 18-25 years, 45-50 years, 60-65 years, and 70-75 years.
Each age group benefits from consultation content tailored to its specific risks. The text defines targeted prevention themes for each group, as well as the remuneration for healthcare professionals conducting these consultations.
This legal framework shifts prevention from a general recommendation to a structured, traceable, and reimbursed medical act. Professionals now have a precise regulatory reference to organize these appointments according to the patient’s age group.
Arboviruses and tiger mosquito: health surveillance progresses in metropolitan France
Arboviruses (dengue, chikungunya, Zika) have been increasing in the metropolitan territory for several years. The establishment of the tiger mosquito in a growing part of the territory makes health alerts recurrent every summer, with regular calls for vigilance in the affected departments.
A strengthened surveillance system is activated annually during the hottest months. It relies on collaboration between regional health agencies, mosquito control operators, and city healthcare professionals responsible for reporting suspected cases.
Why monitoring arboviruses also concerns travelers
Indigenous cases remain minority. The majority of infections are imported by individuals returning from endemic areas.
The rapid reporting of an imported case triggers local mosquito control to curb any secondary transmission. This response relies on mandatory reporting to the ARS, which then coordinates the intervention on the ground.
Active pharmacovigilance: the case of the meningioma risk linked to certain pills
ANSM has alerted on the meningioma risk linked to certain contraceptive pills and contacted 1.6 million women on the pill to inform them and guide them towards appropriate follow-up.
The mechanism relies on cross-referencing Health Insurance databases with prescription data. This method allows for directly identifying the affected patients and sending them a personalized letter, without waiting for spontaneous reporting.
This type of action reflects a change in posture from health authorities. Surveillance is no longer limited to the passive collection of adverse effects; it incorporates a proactive approach to informing exposed patients. For healthcare professionals, this means being able to answer questions from patients who receive this letter and to offer an appropriate assessment.
Prevention and care pathways: regulatory signals to follow in 2026
Several regulatory signals converge towards a common goal: to streamline the care pathway by strengthening the role of paramedical professions. The gradual expansion of prescribing competencies to certain non-physician professionals is among the regularly discussed avenues to address access to care tensions.
In areas where finding a primary care physician is a challenging task, the possibility for other professionals to renew or initiate certain prescriptions represents a direct time-saving for patients. The regulatory framework is still under construction, with a goal of traceability of prescriptions and systematic information of the primary care physician.
- The pathway becomes smoother when the patient obtains a product related to their paramedical care without an intermediate medical consultation.
- Traceability and information sharing between professionals remain the safety conditions set by health authorities, continuing the delegations already granted to pharmacists, midwives, and advanced practice nurses.
The year 2026 sees the coexistence of the legal framework for prevention, reflections on the expansion of the scope of prescribers, and active monitoring of medication and vector risks. These regulatory developments now weigh as heavily as medical advances on the daily lives of patients.
